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Introduction
Current single-cell RNA-sequencing (scRNA-seq) data generated by a variety of technologies such as Drop-seq and SMART-seq, can reveal simultaneously the mRNA transcript levels of thousands of genes in thousands of cells [1] [2] [3] . However, the increased dimensionality makes it challenging to delineate cell types, due to complex and often undefined associations between individual genes and cell-types [4, 5] . It is well accepted that genes are not equally informative in delineating cell types [6, 7] .
Certain genes are only expressed in certain cell types, but not others [8] . Moreover, the expression levels of certain genes cannot be robustly measured (e.g., zero inflated), due to technological bias [9] [10] [11] . Thus, it has become a common practice to retain only highly expressed or highly variable genes for cell populational analysis [12] [13] [14] [15] . Several scRNA-seq data clustering packages (S1 Table) perform marker selection through dimensionality reduction techniques such as principal component analysis and tSNE [16] , which are equivalent to identifying the set of highly variable genes.
Unfortunately, the biological implications and the technical optimality of these gene selection strategies retain unclear, despite their wide use in cell-type clustering.
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Here, we propose an ab initio method, named SCMarker, which applies information-theoretic principles to determine the optimal gene subsets for cell-type identification, without referencing to any known transcriptomic profiles or cell ontologies. The central idea of our method is to select genes that are individually discriminative across underlying cell types, based on a mixture distribution model, and are co-or mutually exclusively expressed with some other genes, due to cell-type specific functional constraints. Although the techniques of applying a mixture distribution model for a set of continuous data points have been widely used in clustering analysis of gene expressions, it is unclear whether this approach can benefit this problem context [17, 18] . In particular, because single-cell gene expression measurements have vast dimensions (>20,000 genes), are highly noisy (e.g., zero-inflated, drop-off errors), and are generated by technologies of varied properties . For example, SMART-seq is aimed at sequencing the entire RNA transcript, while Drop-seq only the 3' end using unique molecular indices (UMI) to track individual transcript [2, 21, 22] . Part of our investigation here is to examine whether the previously applied data analytical techniques can be reapplied in the singlecell data-type that have different properties and population structures. Our main goal is to identify not only cell-types, but also biologically meaningful cell-type markers from scRNA-seq data at accuracies higher than results derived using canonical gene selection strategies.
Materials and Methods

Discriminativeness of gene expressions for subpopulation clustering
By definition, cell-type-discriminative markers (CTDMs) should have distinctive expression levels across cell subpopulations. Therefore, in a dataset with mixed cell subpopulations, the expression level of a CTDM should follow a bi-or multi-modal, instead of a unimodal distribution ( Fig. 1A and B ) [23] [24] [25] . Following this assumption, we quantify the degree of modality based on the probability density distribution (݂) of each gene expression using a Gaussian kernel function, instead of a mixture model which requires knowing the number of mixture components: 
‫ܫ‬
. A gene expression level follows a multi-modal distribution, if it has multiple (ܶ 2 ) local maximum probability density values. Only genes with multimodal probability density distributions are considered as markers. and in the KNMEM (node 1, 2, 6 and 7, connected by green double arrows) can be identified. Marker genes (node 1, 2, 3, 6
and 7) are subsequently selected based on the CMEGPs.
Co-or mutually exclusively expressing gene pairs (CMEGPs)
CTDMs are often co-or mutually exclusively expressed, due to modularized regulatory interactions specific to cell types [26] . Consequently, identifying these CMEGPs, will help identify CTDMs.
Because scRNA-seq data are often sparse with limited sequencing depth [27] 
S can also be represented as a directed graph (Fig 1D) , in which a node denotes a gene and an edge 
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In addition, we calculate a mutually exclusive matrix ‫)ܯ(‬ that measures the pair-wise mutual exclusivity between all the gene pairs through equation (3),
where ‫ܯ‬ represents a directed ݇ -nearest mutually exclusive neighbour (KNMEN) graph (Fig. 1D) . 
Results
Comparison with other marker selection strategies
We applied SCMarker to the scRNA-seq data obtained from 1) 19 melanoma patients, which include 4,645 cells; and 2) 18 head and neck cancer patients, which include 5,902 cells sequenced by the SMART-seq2 platform [28, 29] . In the original studies, each cell in the sets was labelled as a malignant or non-malignant cell through copy number analysis. The expression levels of known marker genes were used to further classify the non-malignant cells, such as T cells, B/plasma cells, macrophages, dendritic cells, mast cells, endothelial cells, fibroblasts, and myocytes. We found that most known marker genes (96%) demonstrated bi/multi-modal distributions across cells (S1 Fig.) .
Overall, around 6% of genes with bi/multi-modal distributions are identified as marker genes, among which half are the known marker genes.
For a fair comparison, we assessed SCMarker results with those obtained under two canonical strategies: selecting genes with A) the highest average expression levels and B) the highest variance across cells. In our experiments, the highest variable genes were determined using Seurat [12] . We used five clustering methods: k-means, Clara, hierarchical clustering, DBSCAN and Seurat to cluster single cells based on the selected markers [30, 31] . Same numbers of clusters are specified for DBSCAN, k-means, Clara, and hierarchical clustering. The adjusted rand index (ARI), which measures the similarity of two sets of clustering results, was used to quantify the consistency between the clustering results and the known cell labels [32] . Compared to marker sets A and B, selected by the canonical strategies, the marker set selected by SCMarker (equal numbers of markers) resulted in a higher ARI with fairly evident margins (Fig. 2) . The conclusion appeared to be robust over a range of ݇ and ݊ parameters and were unaffected by using different clustering methods (S2 Fig.) . We obtained 902 markers from the melanoma data and more distinguishable cell types using SCMarker than using the canonical strategies ( Fig. 3A to C). Better performance of SCMarker was also obtained in analysing the head and neck cancer data (S4 Fig.) . Moreover, the genes selected by
SCMarker had substantially higher degrees of overlap with the known cell-type markers reported in the original publications than the sets returned by other approaches (the same number of 902 top scoring genes were selected for fair comparison), including the "FindMarker" approach in Seurat ( Fig.   3D to G). Notably, SCMarker selected significantly more immune cell surface markers specific to T cytotoxic, T helper, B lymphocyte, and macrophage cells that are likely present in the tumour microenvironment, as indicated by gene set enrichment analysis (S5 Fig.) [33]. 
Application of SCMarker to 3' UMI count data
To avoid introducing biases due to potential overfitting and assess the utility of our approaches on other platforms, we further assessed the utility of SCMarker in analysing the 3' UMI count scRNA-seq data generated by the droplet platforms.
We first analysed a set of 5,602 cells from the cerebellar hemisphere of normal brain tissues generated by . SCMarker selected 699 genes as CTDMs, which differentially expressed across cell subpopulations under the default parameters. Alternatively, the default mode of Seurat led to the selection of 6,111 highest variable genes (HVGs). For comparison, we selected 699 highest expressed genes (HEGs). Although SCMarker selected less markers than Seurat, the clustering result showed a clearer separation than that based on the Seurat HVGs and on the HEGs (Fig. 4A to   C ). In particular, SCMarker successfully delineated Purkinje neurons into purk1 (cluster4, Fig. 4A) and purk2 (cluster7, Fig. 4A ) and recapitulated the differential levels of SORCS3 between two clusters ( Fig. 4D) , which are consistent with the results in the original paper. In contrast, although the Purkinje neurons were clustered into four groups by Seurat (Fig. 4B ), purk1 and purk2 were not well separated (Fig. 4B) , and the expression levels of SORCS3 showed mosaic patterns across the 4 groups (cluster4, 6, 11 and 12, Fig. 4E ). As additional controls, we performed clustering using the top 500 and 1000 Seurat HVGs. That did not result in any improvement (S6 Fig.) .
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Fig 4.
Results on the human brain data. Plotted in tSNE space are 5,602 cells in the cerebellar hemisphere of human brain tissue based on markers selected respectively by (A) SCMarker,(B) the highest variable genes and (C) the highest expressed genes, colored by performing clustering using Seurat. Cell types were labelled consistently as they were in the original paper.
Also plotted are the heatmaps of the top 10 gene expression levels in each cluster derived respectively from (D) SCMarker,(E) the highest variable genes and (F) the highest expressed genes.
We then analysed the scRNA-seq data of 52,698 cells from 5 lung tumours generated by the 10X
Chromium platform (10X Genomics) [35] . SCMarker identified 848 markers under the default parameters, while Seurat identified 1,832 HVGs. We also selected 848 HEGs for comparison.
SCMarker led to 22 clearly distinguishable clusters, while the Seurat HVGs led to 12 and the HEGs led to 18 (Fig. 5A to C) . The 10 highest expressed markers per cluster derived by SCMarker showed a high degree of cluster-specificity in the heatmap (Fig. 5D) . Among the selected markers were the 16 known markers reported by the original study ( Table 1) . SCMarker also discovered multiple putative subtypes for some cell types, such as the T, B, fibroblast, and myeloid cells ( Table 1, Fig. 5A ). For example, cluster 7, 10, 13, 19, and 22 are the B cells expressing known surface marker CD79A (Fig.   5A ), yet cells in cluster 7, 13, 19, and 22 are evidently different from cells in cluster 10, due to differential IGHG1 and BANK1 expression levels (Fig. 5D ). For comparison, we selected the 10 highest expressed genes from the clusters determined by the Seurat HVGs and by the HEGs, respectively ( Fig. 5E and F) . They appeared non-specifically distributed across clusters ( Fig. 5E and   F ). These genes also contained fewer known markers ( Table 1) . For example, cluster 3 determined by the Seurat HVGs contained markers (CLDN5, CAV1 and IFITM3) from 3 cell-types (endothelia, alveolar and B cell, respectively). Most clusters expressed IFITM3, except for clusters 1 and 6 (Fig.   5E ). Only T cell and fibroblast markers appeared to be cluster-specific. As additional controls, we also performed analysis using fewer (i.e., 500 and 1000) Seurat HVGs. That resulted in worse results with fewer known markers and marker-specific clusters (S7 Fig.) .
1 0 Overall, SCMarker demonstrated higher sensitivity and specificity for cell type and cell-type specific marker identification than the alternative approaches. Moreover, markers selected by SCMarker were more significant among genes which were identified by Seurat to define clusters (S8 Fig.) .
Discussion
In this manuscript, we reported a new bioinformatics tool, SCMarker, which performs ab initio cell-type discriminative marker selection from scRNA-seq data. SCMarker operates based on two new information-theoretic metrics: 1) bi/multi-modal distribution of subpopulation-discriminative gene expression in mixed cell populations and 2) co-or mutually-exclusively expressing gene pairs, which quantifies populational structural properties intrinsic to single-cell RNA-seq data. We found that SCMarker can consistently significantly boost cell-type identification accuracy in datasets from a variety of tissues such as cancer and brain, generated by both SMART-seq and Drop-seq platforms.
Because SCMarker does not depend on any prior knowledge, we anticipate that it will prove most useful in discovery settings for analysing cell populations of a high degree of plasticity and heterogeneity [36] . SCMarker can potentially be expanded to analyse other types of single-cell data, including mass cytometry and single cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) data [37, 38] . It can be easily incorporated as a module into current scRNA-seq data analysis workflows to pre-process the cell-gene count/expression matrix before performing further downstream analysis.
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